Just a quick note to let you know that the Adverse Reaction archetype has been published.
The evolution of the archetype from its first iteration uploaded in July 2008 and first ever review in July 2009 through to today has been fragmented and a bit ‘staccato’ with review contributions coming from the openEHR, NEHTA and Nasjonal IKT CKMs at various times through the process, culminating in publication in the international openEHR CKM. I expect that Norway is likely to follow suit very soon, others will utilise it at their own pace.
This published archetype is the result of activity in each of the openEHR, NEHTA and Nasjonal IKT CKMs:
Activity:
First review round 2009 (openEHR)
5 Review rounds Nov 2010 to Jul 2011 (NEHTA)
Further review round 2012 (openEHR)
4 joint review rounds with FHIR community from Jul 2014-Nov 2015 (openEHR)
1 parallel review round by Nasjonal IKT in Norwegian language Jun-Sep 2015 (Norway CKM)
12 Review rounds completed in total, comprising
91 individuals participated from 16 countries
182 individual reviews
0 face to face meetings! All work was done online, including Editorial facilitation of reviewer feedback.
And this is definitely our most complex archetype published to date. It is a ubiquitous concept, but implemented in many different ways and contexts, and the added requirement that flexible extensions will be required for aligned activities such as reporting to government or for clinical trial data.
It is anticipated that an aligned FHIR resource will be made available based on the common clinical content collaboration.
An absolutely phenomenal effort from everyone!
Now we move on to the Medication family of archetypes in the next few days – another extraordinarily complex modelling feat that is currently being coordinated by Ian McNicoll. If you would like to participate please adopt the archetypes you would like to review: http://www.openehr.org/ckm/#showProject_1013.30.27
Kind Regards
Heather
Dr Heather Leslie MBBS FRACGP FACHI Consulting Lead, Ocean Informatics
I think it is a good idea to do some more effort on marketing.
This great archetype, high quality (as far as I can judge is a very good example to publish outside the OpenEHR-communities.
There are many many many who never or only vaguely heard about OpenEHR, and/or don't trust CC-licenses.
I think it must get more under the skin of hospital-management, so they will ask their software-suppliers why they don't work with OpenEHR.
It must get so common, that when someone sees some information, he/she will actually read it.
I took the liberty to translate and summarize the email, and put it on a Dutch language Linked Group, which has 3000 members, with subject EPD.
The members are mostly Dutch managers in health-care and health related software-enterprises.
Just a quick note to let you know that the Adverse Reaction archetype has been published.
The evolution of the archetype from its first iteration uploaded in July 2008 and first ever review in July 2009 through to today has been fragmented and a bit ‘staccato’ with review contributions coming from the openEHR, NEHTA and Nasjonal IKT CKMs at various times through the process, culminating in publication in the international openEHR CKM. I expect that Norway is likely to follow suit very soon, others will utilise it at their own pace.
This published archetype is the result of activity in each of the openEHR, NEHTA and Nasjonal IKT CKMs:
Activity:
First review round 2009 (openEHR)
5 Review rounds Nov 2010 to Jul 2011 (NEHTA)
Further review round 2012 (openEHR)
4 joint review rounds with FHIR community from Jul 2014-Nov 2015 (openEHR)
1 parallel review round by Nasjonal IKT in Norwegian language Jun-Sep 2015 (Norway CKM)
12 Review rounds completed in total, comprising
91 individuals participated from 16 countries
182 individual reviews
0 face to face meetings! All work was done online, including Editorial facilitation of reviewer feedback.
And this is definitely our most complex archetype published to date. It is a ubiquitous concept, but implemented in many different ways and contexts, and the added requirement that flexible extensions will be required for aligned activities such as reporting to government or for clinical trial data.
It is anticipated that an aligned FHIR resource will be made available based on the common clinical content collaboration.
An absolutely phenomenal effort from everyone!
Now we move on to the Medication family of archetypes in the next few days – another extraordinarily complex modelling feat that is currently being coordinated by Ian McNicoll. If you would like to participate please adopt the archetypes you would like to review: http://www.openehr.org/ckm/#showProject_1013.30.27
Kind Regards
Heather
Dr Heather Leslie MBBS FRACGP FACHI Consulting Lead, Ocean Informatics